LoginRegister
    Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladderUrovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder
    Ministry of Science and Technology invites Concept Proposals for CAR T Cell therapyMinistry of Science and Technology invites Concept Proposals for CAR T Cell therapy
    TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug UmbralisibTG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib
    PM Modi gets emotional while interacting with beneficiaries of PMBJPPM Modi gets emotional while interacting with beneficiaries of PMBJP
    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stentAfter giving exemption, NPPA asks Meril Life Sciences for MRP of its stent
    Hester Biosciences appoints Sahil Shah as CFO, Dr Rahul Srivastava as Vice PresidentHester Biosciences appoints Sahil Shah as CFO, Dr Rahul Srivastava as Vice President
    Minister apprises parliament about Indigenously Procured Medical DevicesMinister apprises parliament about Indigenously Procured Medical Devices
    Acacia Pharma gets USFDA nod of BARHEMSYS® (amisulpride) for Treatment, Prevention of PONVAcacia Pharma gets USFDA nod of BARHEMSYS® (amisulpride) for Treatment, Prevention of PONV
    Takeda Receives Positive CHMP Opinion for Crohn Disease drugTakeda Receives Positive CHMP Opinion for Crohn Disease drug
    CryoLife receives CE Mark for hybrid stent graft system E-vita Open NEO™CryoLife receives CE Mark for hybrid stent graft system E-vita Open NEO™
    On sidelines of Janaushadi Diwas, PM Modi appeals for handwashing, habit of NamasteOn sidelines of Janaushadi Diwas, PM Modi appeals for handwashing, habit of Namaste
    NPPA revises price for Ringer lactate -RL injection with special packagingNPPA revises price for Ringer lactate -RL injection with special packaging
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X